GeneTex
  • Country / Location Selection

United States (US)

CACNA2D1 blocking peptide

Cat. No. GTX89045-PEP

Species

Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89045.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-QEIFNKYNKDKKVR

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2Delta 1 , Cacna2 , Cacnl2A , Cchl2A , Linc01112 , Lncrna-N3 , Cacna2D1

Background

The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]

Research Area

REFERENCE

There are currently no references for CACNA2D1 blocking peptide (GTX89045-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for CACNA2D1 blocking peptide (GTX89045-PEP). Be the first to share your experience with this product.
Package List Price ($)
$ 239